Human placenta-derived amniotic epithelial cells as a new therapeutic hope for COVID-19-associated acute respiratory distress syndrome (ARDS) and systemic inflammation

Human placenta-derived amniotic epithelial cells as a new therapeutic hope for COVID-19-associated acute respiratory distress syndrome (ARDS) and systemic inflammation

Abstract Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which causes coronavirus disease 2019 (COVID-19), has become in the spotlight regarding the serious early and late complications, including acute respiratory distress syndrome (ARDS), systemic inflammation, multi-organ failure an...

Full description

Bibliographic Details
Main Authors: Amirhesam Babajani, Kasra Moeinabadi-Bidgoli, Farnaz Niknejad, Hamidreza Rismanchi, Sepehr Shafiee, Siavash Shariatzadeh, Elham Jamshidi, Mohammad Hadi Farjoo, Hassan Niknejad
Format: Article
Language:English
Published: BMC 2022-03-01
Series:Stem Cell Research & Therapy
Subjects:
ARDS
COVID-19
Amniotic membrane
Epithelial stem cells
Immunomodulation
Regenerative medicine
Online Access:https://doi.org/10.1186/s13287-022-02794-3

Internet

https://doi.org/10.1186/s13287-022-02794-3

Similar Items